Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice

Abstract

MMPs are implicated in LV remodeling after acute myocardial infarction (MI).To analyze the role of MMP-2, we generated MI by ligating the left coronary artery of MMP-2-KO and WT mice, the latter of which were administered orally an MMP-2-selective inhibitor or vehicle (TISAM).The survival rate was significantly higher in MMP-2-KO and TISAM-treated mice than in control WT mice.The main cause of mortality in control WT mice was cardiac rupture, which was not observed in MMP-2-KO or TISAM-treated mice.Control WT mice, but not MMP-2-KO or TISAM-treated mice, showed activation of the zymogen of MMP-2, strong gelatinolytic activity, and degradation of ECM components, including laminin and fibronectin, in the infarcted myocardium.Although infarcted cardiomyocytes in control WT mice were rapidly removed by macrophages, the removal was suppressed in MMP-2-KO and TISAM-treated mice.Macrophage migration was induced by the infarcted myocardial tissue from control WT mice and was inhibited by treatment of macrophages with laminin or fibronectin peptides prior to migration assay.These data suggest that inhibition of MMP-2 activity improves the survival rate after acute MI by preventing cardiac rupture and delays post-MI remodeling through a reduction in macrophage infiltration.Nonstandard abbreviations used: fMLP, formyl-Met-Leu-Phe; GBSS, Gey's balanced saline solution; MCP-3, monocyte chemoattractant protein-3; MI, myocardial infarction; TNC buffer, 50 mM Tris-HCl buffer (pH 7.6), 0.15 M NaCl, 10 mM CaCl2, 0.05% Brij 35, 0.02% NaN3. Conflict of interest:The authors have declared that no conflict of interest exists.